Thermo Fisher Scientific has completed the acquisition of CorEvitas, a provider of registry data and analytic services, from Audax Private Equity for $912.5 million in...
Thermo Fisher Scientific has completed the acquisition of CorEvitas, a provider of registry data and analytic services, from Audax Private Equity for $912.5 million in...
US scientific services supplier Thermo Fisher Scientific has agreed to acquire CorEvitas, a provider of registry data and analytic services, from Audax Private Equity for...
A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...
Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are...
Bio-Rad Laboratories is in talks to merge with fellow life-sciences company Qiagen in a deal that could be worth more than $10 billion, US business newspaper Wall Street...
Thermo Fisher Scientific has completed the planned expansion of its US dry powder media manufacturing capacity in Grand Island, New York, which it said is designed to...
Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...
